Search Results 261-270 of 18648 for hepatitis
... hepatitis C no longer a barrier. Health & Wellness. Mayo Clinic Q&A podcast: Expanding the donor pool – hepatitis C no longer a barrier to transplant. Jennifer ...
Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 ...
Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C. Transplant Direct. 2021 Jan; 7(1):e635. Epub 2020 ...
While therapies have been available to treat some forms of liver disease, including hepatitis C and autoimmune hepatitis, options have been more limited ...
In-depth. Abdominal aortic aneurysm · Acute liver failure · Addison's disease · Alcoholic hepatitis · Alpha-gal syndrome · Anaphylaxis · Aneurysms.
Alcoholic hepatitis · Autoimmune hepatitis · Cholangiocarcinoma · Cirrhosis · Esophageal varices · Hemochromatosis · Hepatic encephalopathy · Hepatitis B ...
Hepatitis B; Hepatitis infectious disease; Hepatocellular carcinoma · Hepatopulmonary syndrome · Liver cancer · Liver problems · Nonalcoholic fatty liver ...
Alcoholic hepatitis; Alcoholic liver disease; Autoimmune hepatitis · Cirrhosis; Fontan-associated liver disease; Hemochromatosis · Hepatitis B · Hepatitis C ...
MRE determines the stiffness (fibrosis) of the liver in patients with hepatitis C without needlesticks. This technology makes treating liver disease easier ...
s, Liver problems, Hepatitis C, Primary sclerosing cholangitis, Hepatitis B, Cholangiocarcinoma, Liver cancer, Alcoholic hepatitis, Autoimmune hepatitis ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.